Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)
Part of paid clinical trials in Salt Lake City, Utah.
- Sponsor
- University of Utah
- Study ID
- NCT07599943
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- Text Messages (TM+) — BEHAVIORALA message informs the participants that a Registered Nurse (RN) from the Hub will call them about shared decision making (SDM) and LCS.
- Chatbot (CA) — BEHAVIORALAccess to a chatbot for frequently asked questions about LCS
- Video (VID) — BEHAVIORALAn educational video about LCS
- Reactive Patient Navigation (RPN) — BEHAVIORALRPN to help complete the LCS appointment. RPN requires the participant to initiate the PN request
- Proactive Patient Navigation (PPN) — BEHAVIORALProactive patient navigation to help complete the LCS appointment. PPN does not require the participant to initiate the PN request and instead is a proactive call to the participant.
Study Details
The long-term goal of Lung Sequential Multiple Assignment Randomized Trial (LungSMART) Utah is to increase the reach of Low-Dose Computed Tomography (LDCT) screening for lung cancer (hereafter referred to as Lung Cancer Screening or LCS) at scale in low-resource healthcare settings.
Key Dates
- Start date
- Aug 31, 2026
- Status verified
- May 2026
- Primary completion
- Apr 30, 2030
- Completion
- Apr 30, 2030
Study Design
- Enrollment
- 18,894 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- PREVENTION
Arms
- Other: Stage 1: Repeated Text Messages (TM+)Participants will receive up to nine text messages containing eligibility questions, along with up to nine reminder messages. If a participant successfully responds to the eligibility questions, no more messages will be sent. If a participant does not respond to the eligibility questions after receiving a text message, they will receive a reminder message three days later, prompting them to answer the questions.
- Other: Stage 1: Repeated Text Messages and Chatbot (TM+/CA)Participants will receive up to nine text messages containing eligibility questions, along with up to nine reminder messages. If a participant successfully responds to the eligibility questions, no more messages will be sent. If a participant does not respond to the eligibility questions after receiving a text message, they will receive a reminder message three days later, prompting them to answer the questions. Participants will have access to a Lung Cancer Screening (LCS) Chatbot delivered via Short Message Service (SMS).
- Other: Stage 1: Repeated Text Messages and Video (TM+/VID)Participants will receive up to nine text messages containing eligibility questions, along with up to nine reminder messages. If a participant successfully responds to the eligibility questions, no more messages will be sent. If a participant does not respond to the eligibility questions after receiving a text message, they will receive a reminder message three days later, prompting them to answer the questions. Participants can watch an educational video via SMS.
- Other: Stage 1: Repeated Text Messages, Chatbot, and Video (TM+/CA/VID)Participants will receive up to nine text messages containing eligibility questions, along with up to nine reminder messages. If a participant successfully responds to the eligibility questions, no more messages will be sent. If a participant does not respond to the eligibility questions after receiving a text message, they will receive a reminder message three days later, prompting them to answer the questions. Participants will have access to a Lung Cancer Screening (LCS) Chatbot delivered via SMS. Participants can watch an educational video via SMS.
- Other: Stage 2: Chatbot and Reactive Patient Navigation (CA/RPN)Reactive Patient Navigation (RPN) requires the participant to initiate the patient navigation (PN) request. Participants receive up to three text messages scheduled four weeks apart.
- Other: Stage 2: Chatbot and Proactive Patient Navigation (CA/PPN)Proactive Patient Navigation (PPN) does not require the participant to initiate the PN request and instead is a proactive call to the participant. Participants receive up to three text messages scheduled four weeks apart.
Primary Outcome Measure
Stage 1: Completion of eligibility assessment [ Time Frame: up to 18 weeks ]
Central Contacts
- Indy Li, MS801-213-5697
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Huntsman Cancer Institute/University of Utah | Salt Lake City | Utah | 84112 | David Wetter, PhD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Salt Lake City, UT
By condition
By specialty
By research site
Related Studies
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California
- Improving Care for Rural Patients With Solid TumorsRecruiting · University of Colorado, Denver · Aurora, Colorado
- Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor MalignanciesPHASE1 · Recruiting · Circle Pharma · Sarasota, Florida
- Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossPHASE1/PHASE2 · Recruiting · Tango Therapeutics, Inc. · Scottsdale, Arizona